ArticleJournal of managed care & specialty pharmacy2022

Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin.

Eugene E Wright et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.